Prevalence of Metabolic Syndrome X in patients diagnosed with Chronic Kidney Disease undergoing dialysis

<p><strong>Introduction:</strong> Metabolic syndrome X (MSX) encompasses risk factors such as abdominal obesity, hypertension, dyslipidemia, and insulin resistance, which significantly increase cardiovascular morbidity and mortality. In patients with chronic kidney disease (CKD), the presence of MSX is even more relevant, as it accelerates disease progression and increases cardiovascular complications. A retrospective, descriptive study was conducted in which patients treated at the Hemodialysis Unit of Dr. Amador Guerrero Hospital were evaluated, and the presence of cardiovascular risk factors and components of MSX was quantified. <strong>Justification:</strong> Metabolic syndrome is highly prevalent in patients with chronic kidney disease and increases cardiovascular risk, making its identification essential to improve clinical outcomes. <strong>Methodology:</strong> Patients with chronic kidney disease undergoing dialysis in the province of Colón during 2005 were studied. Anthropometric and laboratory data were collected, and metabolic syndrome was diagnosed according to the NCEP/ATP III (2005) criteria. Data analysis was performed using EPI-INFO 6.0. <strong>Results:</strong> A prevalence of 23.7% of MSX was observed among patients treated at the unit. Of these patients, 88.9% presented abdominal obesity and arterial hypertension. However, only abdominal obesity and insulin resistance (measured as fasting hyperglycemia) were statistically significant for the presence of MSX in CKD patients, with reported ORs of 38.4 (95% CI: 3.88379.70, p<0.05) and 6.28 (95% CI: 1.2331.95, p<0.05), respectively. <strong>Conclusion:</strong> The prevalence of MSX in the studied population was 23.7%. Abdominal obesity and insulin resistance significantly increased the likelihood of MSX. Furthermore, current evidence suggests that genetic variants may predispose CKD patients to the development of MSX, opening new avenues for research.</p>

Authors

Institutions

Publication Details

Journal
Genetics and Clinical Genomics
Published
2025-08-31
DOI
https://doi.org/10.37980/im.journal.ggcl.en.20252691
Primary Topic
Diet, Metabolism, and Disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prevalence of Metabolic Syndrome X in patients diagnosed with Chronic Kidney Disease undergoing dialysis

Jorge David Mendez-Rios
Genetics and Clinical Genomics
Diet, Metabolism, and Disease
article

Prevalence of Metabolic Syndrome X in patients diagnosed with Chronic Kidney Disease undergoing dialysis

Jorge David Mendez-Rios
article en

Abstract

<p><strong>Introduction:</strong> Metabolic syndrome X (MSX) encompasses risk factors such as abdominal obesity, hypertension, dyslipidemia, and insulin resistance, which significantly increase cardiovascular morbidity and mortality. In patients with chronic kidney disease (CKD), the presence of MSX is even more relevant, as it accelerates disease progression and increases cardiovascular complications. A retrospective, descriptive study was conducted in which patients treated at the Hemodialysis Unit of Dr. Amador Guerrero Hospital were evaluated, and the presence of cardiovascular risk factors and components of MSX was quantified. <strong>Justification:</strong> Metabolic syndrome is highly prevalent in patients with chronic kidney disease and increases cardiovascular risk, making its identification essential to improve clinical outcomes. <strong>Methodology:</strong> Patients with chronic kidney disease undergoing dialysis in the province of Colón during 2005 were studied. Anthropometric and laboratory data were collected, and metabolic syndrome was diagnosed according to the NCEP/ATP III (2005) criteria. Data analysis was performed using EPI-INFO 6.0. <strong>Results:</strong> A prevalence of 23.7% of MSX was observed among patients treated at the unit. Of these patients, 88.9% presented abdominal obesity and arterial hypertension. However, only abdominal obesity and insulin resistance (measured as fasting hyperglycemia) were statistically significant for the presence of MSX in CKD patients, with reported ORs of 38.4 (95% CI: 3.88379.70, p<0.05) and 6.28 (95% CI: 1.2331.95, p<0.05), respectively. <strong>Conclusion:</strong> The prevalence of MSX in the studied population was 23.7%. Abdominal obesity and insulin resistance significantly increased the likelihood of MSX. Furthermore, current evidence suggests that genetic variants may predispose CKD patients to the development of MSX, opening new avenues for research.</p>

Genetics and Clinical Genomics
Centre hospitalier de l'Université Laval (CA)
Openalex Percentile: Top 68%
Diet, Metabolism, and Disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.